T-CiRA is a unique, long-term joint research program that was established by Takeda and the Center for iPS Cell Research and Application (CiRA), Kyoto University. From our research facilities in Shonan iPark in Japan, the program is led by Professor Shinya Yamanaka, Director Emeritus of CiRA and recipient of the 2012 Nobel Prize in Physiology or Medicine.
The program is mapping uncharted territory to explore breakthrough clinical applications by use of evolving technologies with iPS (induced pluripotent stem) cells. The ultimate aim is to develop innovative treatments, alongside cell and gene therapies, that address unmet patient needs in neuro-psychiatric conditions, cancer, complex muscle diseases and gastrointestinal disorders.